tiprankstipranks
Catalyst Biosciences Inc (CBIO)
NASDAQ:CBIO
Holding CBIO?
Track your performance easily

Catalyst Biosciences (CBIO) Stock Investors

753 Followers
Based on 697,436 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CBIO
On average, investors allocate 3.73% of their portfolios to CBIO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 697,436 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CBIO

0.9%
Last 7
Days
3.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CBIO, out of 697,436 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CBIO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 12,805 investors who made their portfolios public
The table shows changes in CBIO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CBIO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.44%
-0.55%
-3.88%
332.53M
Healthcare
Roku
5.06%
-0.60%
-1.37%
6.99B
Technology
Blink Charging Co
4.37%
-0.30%
+1.52%
153.36M
Utilities
Assertio Therapeutics
3.05%
-0.85%
-5.37%
195.53M
Healthcare
Micron
5.63%
-0.68%
-2.10%
72.55B
Technology
ChargePoint Holdings
4.11%
-0.24%
-0.48%
885.73M
Technology
Block
4.16%
+0.38%
+0.63%
21.55B
Technology
Li Auto
5.64%
-0.10%
+1.22%
28.83B
Consumer Cyclical
AMC Entertainment
5.49%
-0.63%
-2.07%
1.98B
Consumer Cyclical
Merck & Company
4.52%
+0.06%
-1.64%
260.55B
Healthcare
Based on the activity of 697,436 active portfolios
Open your Smart Portfolio

CBIO Investor Analysis

CBIO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.0%
of CBIO holders
are under 35
Average Segment Performance
Average P/E Ratio-31.97
Beta9.63
Dividend Yield7.16%
CBIO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.4%
of CBIO holders
are between 35–55
Average Segment Performance
Average P/E Ratio-28.67
Beta14.45
Dividend Yield7.59%
CBIO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.6%
of CBIO holders
are over 55
Average Segment Performance
Average P/E Ratio-21.72
Beta5.94
Dividend Yield7.30%
Overview of age group and performance of CBIO stock investors
See who invests in CBIO according to age group and performance.

FAQ

How many retail Investors hold CBIO?
<0.1% of TipRanks' retail investors hold CBIO in their portfolios.
    What is CBIO Investor Sentiment?
    CBIO’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CBIO in the last 7 days?
      ▼ 0.9% of TipRanks' retail investors changed their holding of CBIO in the last 7 days.
        What percentage of retail investors changed their holding of CBIO in the last 30 days?
        ▼ 3.2% of TipRanks' retail investors changed their holding of CBIO in the last 30 days.
          What is the average age of retail investors who hold CBIO?
          The average age of CBIO Holders is between 35–55.
            What other stocks have CBIO investors also bought?
            CBIO Investors also bought CHRS, ROKU, BLNK, ASRT, MU, CHPT, SQ, LI, AMC, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              BIOBio-Rad Laboratories
              OPCHOption Care Health
              LCTXLineage Therap
              IMNNImunon
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis